Abstract

Introduction. SARS-CoV-2 causes multiorgan damage, with a predilection to the respiratory epithelium. Chest imaging studies have been decisive in many pathologies and during the recent pandemic was no exception. In the follow-up with chest tomography post-COVID-19 in several series, persistence of lesions after discharge and over several months has been observed. The aim of this study was to describe the tomographic findings in patients with follow-up for up to one year after hospital discharge for moderate severe COVID-19. Materials and methods. Retrospective, observational study of patients hospitalized for moderate-severe COVID-19 from March 2020 to March 2022 at ISSSTE hospital, Chiapas-Mexico, with positive SARS-CoV-2 RT-PCR test, hospitalization CT and post-discharge follow-up (0-4 months; 4-8 months; 8-12 months). The terminology of the Fleischner company was used. In addition, the extension per affected lobe was evaluated (>75%, 75-50%, 50-25%, <25%). Results. 27 patients were studied, 74% men, average age 56 years. The predominant tomographic pattern at admission was mixed with 56% and lung extension >75%; glass depulpation 30% and consolidation 11%. At the fourth and eighth month the mixed pattern was the most frequent, at the twelfth month it persisted in 33% of the patients and in 30% of the cases the tomography was normal. As the months passed, the extent of the damage became more limited. Conclusion: The follow-up with tomography in moderate-severe COVID-19 is indisputable. It allows precise identification of the tomographic pattern at different times of the disease, optimization of treatment and reduction of sequelae.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call